Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of using transdominant negative retroviral integrase in the treatment of retroviral infection

Method of using transdominant negative retroviral integrase in the treatment of retroviral infection

US Patent 5908923 · Granted Jun 1, 1999

Estimated economic value: $467,702,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigenic multimeric respiratory syncytial virus polypeptides2025
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and 2025
Trispecific binding proteins, methods, and uses thereof2025
Virus-like particles and methods of use2024
Antigenic Epstein Barr virus polypeptides2024
Antigenic respiratory syncytial virus polypeptides2024
Antigenic epstein barr virus polypeptides2024
Epstein-barr virus vaccines2024
Method for producing chikungunya virus (CHIKV) virus-like particles comprising t2024
Antigenic OspA polypeptides2024
Trispecific and/or trivalent binding proteins2024
Chimpanzee adenoviral vector-based filovirus vaccines2024